Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Alivus Life Sciences Ltd.

NSE : ALIVUSEQ BSE : 543322 ISIN CODE : INE03Q201024Industry : Pharmaceuticals

News

  • Alivus Life Sciences - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 17 Apr 2025 | 14:46 | Dion Global

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Alivus Life Scien...more...

  • Alivus Life Sciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025 15 Apr 2025 | 07:00 | Dion Global

    As of March 2025 74.99% is owned by Indian Promoters and 25.01% by Public. Institutional holds 11.76% (Insurance Companies 0.22%) and Non-In...more...

  • Alivus Life Sciences - General Updates 03 Apr 2025 | 19:30 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about General Updatesmore...

  • Alivus Life Sciences - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio 03 Apr 2025 | 19:26 | Dion Global

    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015more...

  • Alivus Life Sciences - Acquisition-XBRL 02 Apr 2025 | 17:21 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding Acquisitionmore...

  • Alivus Life Sciences - Acquisition 02 Apr 2025 | 16:40 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Acquisitionmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Acquisition 02 Apr 2025 | 16:31 | Dion Global

    Intimation of Share Purchase cum Subscription Shareholders Agreement and Power Supply Agreement between Alivus Life Sciences Limited (formerly Glenma...more...

  • Alivus Life Sciences - Alteration Of Capital and Fund Raising-XBRL 07 Mar 2025 | 17:07 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding Allotment of Securitiesmore...

  • Alivus Life Sciences - ESOP/ESOS/ESPS 07 Mar 2025 | 17:04 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding Allotment of 4190 equity Shares.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 07 Mar 2025 | 16:59 | Dion Global

    Allotment of Equity Shares under the Glenmark Life Sciences Limited - Employee Stock Option Scheme 2021 .more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 03 Mar 2025 | 14:15 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 03 Mar 2025 | 14:11 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting.more...

  • Alivus Life Sciences - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent 27 Feb 2025 | 14:27 | Dion Global

    ALIVUS LIFE SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transf...more...

  • Alivus Life Sciences - Demise 27 Feb 2025 | 14:15 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding Demise of Mr. Vijaykumar Ratilal Shah Independent Director of the company o...more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Change in Directorate 27 Feb 2025 | 14:13 | Dion Global

    Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Sad demise of Mr. Vijaykumar Ratilal Shah (DIN: 00376570) Independent Director of the...more...

  • Alivus Life Sciences - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 26 Feb 2025 | 14:15 | Dion Global

    Please find attached herewith disclosure under Regulation 30 of SEBI (LODR) Regulations 2015.more...

  • Alivus Life Sciences - Action(s) initiated or orders passed 26 Feb 2025 | 14:13 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Action(s) initiated or orders passedmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 21 Feb 2025 | 17:17 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 21 Feb 2025 | 17:13 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - General Updates 31 Jan 2025 | 16:38 | Dion Global

    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015more...

Enter Stock

DOW Jones40280.940.42%
Nasdaq17388.710.03%
S&P 5005536.520.20%
Nikkei 22535839.990.38%
Hang Seng22027.890.21%
Shanghai Composite3288.41-0.20%
Sensex80218.371.27%
NSE Index24328.51.20%
BSE 100LCTMC8972.671.24%
BSE Auto 500621.65%
BSE Bharat228402.691.60%
BSE CPSE 3692.441.98%

Commodity

Gold95244-0.50%
Silver974420.01%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 85.58(0.08 %)
GBP/INR 113.82(0.25 %)
EUR/INR 97.12(0.07 %)
JPY/INR 0.60(-0.48 %)
CAD/INR 61.57(-0.28 %)
HKD/INR 11.01(-0.09 %)